ESPE Abstracts (2019) 92 RFC6.1

ESPE2019 Rapid Free Communications Bone, Growth Plate and Mineral Metabolism Session 2 (6 abstracts)

EFTUD2 Gene Deficiency Disturbs Maturation of Osteoblast and Inhibits Chondrocyte Differentiation via Activated p53 Signaling

Jing Wu 1 , Yi Yang 2 , You He 3 , Qiang Li 4 , Xu Wang 5 , Chengjun Sun 1 , Lishun Wang 6 , Yu An 7 & Feihong Luo 1


1Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University, Shanghai, China. 2Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai, China. 3Shanghai Synchrotron Radiation Facility, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China. 4Translational Medical Center for Development and Disease, Shanghai Key Laboratory of Birth Defect, Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai, China. 5Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China. 6Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China. 7Human Phenome Institute, Fudan University, Shanghai, China


Mandibulofacial dysostosis with microcephaly (MFDM) is characteristic of multiple skeletal anomalies comprising craniofacial anomalies/dysplasia, microcephaly, dysplastic ears, choanal atresia and short stature. Loss of function mutations of EFTUD2 were previously reported in MFDM, however, the mechanism underlying EFTUD2-associated skeletal dysplasia remains unclear. Here, we identified a novel frameshift mutation of EFTUD2 in a MFDM Chinese patient with craniofacial dysmorphism including ear canal structures and microcephaly, mild intellectual disability and developmental delay. We have generated a zebrafish model of eftud2 deficiency and consistent phenotype of mandibular bone dysplasia and otolith loss were observed. We have also shown that EFTUD2 deficiency significantly inhibited proliferation, differentiation and maturation in human calvarial osteoblasts (HCO) and articular chondrocytes (HC-a). RNA-Seq analysis uncovered activated TP53 signaling with increased phosphorylation of TP53 protein and upregulation of five TP53 downstream target genes (FAS, STEAP3, CASP3, P21 and SESN1) both in HCO and in eftud2-/- zebrafish. Additionally, inhibition of p53 by morpholino significantly reduced the mortality of eftud2-/- larvae. Together, our results suggest that EFTUD2 may participate in the maturation of osteoblast and is necessary for chondrocyte differentiation, possibly via activation of the TP53 signaling, and thereby, leading to skeletal anomalies in vertebrates.

Volume 92

58th Annual ESPE

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.